Literature DB >> 9924284

Prebiotics and synbiotics: concepts and nutritional properties.

M B Roberfroid1.   

Abstract

The main role of diet is to provide enough nutrients to meet the requirements of a balanced diet, while giving the consumer a feeling of satisfaction and well-being. The most recent knowledge in bioscience supports the hypothesis that diet also controls and modulates various functions in the body, and, in doing so, contributes to the state of good health necessary to reduce the risk of some diseases. It is such an hypothesis which is at the origin both of the concept of 'functional food' and the development of a new scientific discipline of 'functional food science'. In the context of this paper the potential 'functional foods' to be discussed are the prebiotics and the synbiotics. The prebiotics developed so far are the non-digestible oligosaccharides and especially the non-digestible fructans among which chicory fructans play a major role. The chicory fructans are beta (2-1) fructo-oligosaccharides classified as natural food ingredients. They positively affect various physiological functions in such a way that they are already or may, in the future, be classified as functional food ingredients for which claims of functional effects or of disease risk reduction might become authorized. They are classified as prebiotic and have been shown to induce an increase in the number of bifidobacteria in human faecal flora. As part of a synbiotic-type product, they are already bifidogenic at a dose of 2.75 g/d and the effect lasts for at least 7 weeks. The other potential functional effects are on the bioavailability of minerals, but also, and more systemically, on the metabolism of lipids. Potential health benefits may concern reduction of the risk of intestinal infectious diseases, cardiovascular disease, non-insulin-dependent diabetes, obesity, osteoporosis and cancer. However, except for the prebiotic effect, and tentatively the improvement of calcium bioavailability, the evidence to support such effects is still missing in humans though hypotheses already exist to justify nutrition studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924284

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  28 in total

1.  Probiotics in the Treatment of Diarrheal Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria.

Authors:  H Kaplan; R W Hutkins
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

3.  Intestinal Microbiome, Akkermansia muciniphila, and Medical Nutrition Therapy.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-10

4.  The emerging therapeutic role of probiotics in inflammatory bowel disease.

Authors:  Matthew Chandler; Eric Wollins; Anastasia Toles; Marie Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-09

5.  Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function.

Authors:  Maciej Chichlowski; Guillaume De Lartigue; J Bruce German; Helen E Raybould; David A Mills
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

6.  In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota.

Authors:  Shahrul R Sarbini; Sofia Kolida; Thierry Naeye; Alexandra Einerhand; Yoann Brison; Magali Remaud-Simeon; Pierre Monsan; Glenn R Gibson; Robert A Rastall
Journal:  Appl Environ Microbiol       Date:  2011-06-10       Impact factor: 4.792

7.  Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species.

Authors:  B A Rabiu; A J Jay; G R Gibson; R A Rastall
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

8.  Determination of Differentially Expressed Genes Involved in Arabinoxylan Degradation by Bifidobacterium longum NCC2705 Using Real-Time RT-PCR.

Authors:  Patricia Savard; Denis Roy
Journal:  Probiotics Antimicrob Proteins       Date:  2009-04-28       Impact factor: 4.609

9.  Characterization and Antioxidant Property of Probiotic and Synbiotic Yogurts.

Authors:  Arenahalli Ningegowda Madhu; Nanjaiah Amrutha; Siddalingaiya Gurudutt Prapulla
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

10.  Randomised clinical trial of synbiotic therapy in elective surgical patients.

Authors:  A D G Anderson; C E McNaught; P K Jain; J MacFie
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.